Stage 2 Lung Adenocarcinoma: Biomarkers & Treatment Approaches – Case-Based Panel Discussions

For this year’s update to the Case-Based Panel Discussions program, we are pleased to work with Drs. Ana Velazquez Mañana, Medical Oncology Fellow, UCSF Helen Diller Family Comprehensive Cancer Center, Stephen Liu, Associate Professor of Medicine, Georgetown University, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, and Justin Gainor, Director, Center for Thoracic Cancers, Director of Targeted Immunotherapy, Associate Professor of Medicine at Harvard Medical School. 

In this series, the doctors discuss a variety of cases based on real-life scenarios. In this video Drs. Velazquez-Manana, Liu, and Gainor discuss a 66-year-old patient with clinical stage 2 Lung Adenocarcinoma, how to utilize biomarker testing, and treatment approaches.

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.

We thank our sponsors for this year’s support! #Merck #Genentech #Lilly